HUN

Huntsman Corp

Add to Watchlist

Advanced Chart

9.460

-0.04(-0.421%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

9.560

Open

9.560

VWAP

9.44

Vol

4.38M

Mkt Cap

1.64B

Low

9.340

Amount

41.40M

EV/EBITDA(TTM)

10.50

Total Shares

173.00M

3.54B

EV/OCF(TTM)

11.84

P/S(TTM)

0.28

Huntsman Corporation is a manufacturer of diversified organic chemical products. It operates through three segments: Polyurethanes, Performance Products and Advanced Materials. The Polyurethanes product segment includes methylene diphenyl diisocyanate, polyols, and thermoplastic polyurethane products. The Performance Products segment is engaged in the manufacturing and sale of amines and maleic anhydride and serves a variety of consumer and industrial end markets. Its Advanced Materials segment includes technologically advanced epoxy, phenoxy, acrylic, polyurethane, mercaptan and acrylonitrile butadiene-based polymer products as well as carbon nanomaterials. Its products comprise different chemicals and chemical formulations, which it markets globally to a wide range of consumers that consist primarily of industrial and building product manufacturers. Its products are used in a range of applications, including adhesives, aerospace, automotive, coatings and construction, and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

1.46B

+3.52%

-0.061

-44.35%

1.44B

-0.96%

-0.142

-43.11%

1.46B

-5.5%

-0.104

-204.4%

Estimates Revision

The market is revising Downward the revenue expectations for Huntsman Corporation (HUN) for FY2025, with the revenue forecasts being adjusted by -3.63% over the past three months. During the same period, the stock price has changed by -26.84%.

Revenue Estimates for FY2025

Revise Downward

-3.63%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+76.27%

In Past 3 Month

Stock Price

Go Down

-26.84%

In Past 3 Month

12 Analyst Rating

20.08% Upside

Wall Street analysts forecast HUN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUN is 11.36 USD with a low forecast of 9.00 USD and a high forecast of 18.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

9 Hold

1 Sell

Hold

20.08% Upside

Current: 9.460

Low

9.00

Averages

11.36

High

18.00

20.08% Upside

Current: 9.460

Low

9.00

Averages

11.36

High

18.00

Citi

Neutral

downgrade

$11 -> $9

2025-08-04

Reason

Citi

Price Target

$11 -> $9

2025-08-04

downgrade

Neutral

Reason

Citi lowered the firm's price target on Huntsman to $9 from $11 and keeps a Neutral rating on the shares. The firm cut the company's estimates post the earnings report.

UBS

Joshua Spector

Neutral

downgrade

$11 -> $10

2025-08-01

Reason

UBS

Joshua Spector

Price Target

$11 -> $10

2025-08-01

downgrade

Neutral

Reason

UBS analyst Joshua Spector lowered the firm's price target on Huntsman to $10 from $11 and keeps a Neutral rating on the shares. Huntsman's balance sheet is in focus amid an expectations for a lack of seasonal improvement, the analyst tells investors in a research note.

Mizuho

John Roberts

Neutral

downgrade

$14 -> $11

2025-07-15

Reason

Mizuho

John Roberts

Price Target

$14 -> $11

2025-07-15

downgrade

Neutral

Reason

Mizuho analyst John Roberts lowered the firm's price target on Huntsman to $11 from $14 and keeps a Neutral rating on the shares. The firm updated price targets in chemicals and packaging ahead of the Q2 reports. It says the new targets reflect the recent market multiple recovery. Mizuho's top picks are all specialty and defensive names: Corteva (CTVA), Crown (CCK) and Linde (LIN). A pause in tariffs likely pulled forward some demand, which could create a year-end slowdown, the analyst tells investors in a research note.

Citi

Patrick Cunningham

Neutral

downgrade

$12 -> $11

2025-07-10

Reason

Citi

Patrick Cunningham

Price Target

$12 -> $11

2025-07-10

downgrade

Neutral

Reason

Citi analyst Patrick Cunningham lowered the firm's price target on Huntsman to $11 from $12 and keeps a Neutral rating on the shares. The firm has a mixed view on chemicals heading into the Q2 reports given tariff uncertainty. It believes macro headwinds weighed on demand and drove Q2 volumes below expectations.

UBS

Neutral

downgrade

$28 -> $26

2025-07-09

Reason

UBS

Price Target

$28 -> $26

2025-07-09

downgrade

Neutral

Reason

UBS lowered the firm's price target on Huntsman to $26 from $28 and keeps a Neutral rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.

Alembic Global

Overweight

downgrade

$22 -> $18

2025-05-19

Reason

Alembic Global

Price Target

$22 -> $18

2025-05-19

downgrade

Overweight

Reason

Alembic Global lowered the firm's price target on Huntsman to $18 from $22 and keeps an Overweight rating on the shares.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Huntsman Corp (HUN.N) is -32.65, compared to its 5-year average forward P/E of 27.89. For a more detailed relative valuation and DCF analysis to assess Huntsman Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

27.89

Current PE

-32.65

Overvalued PE

64.67

Undervalued PE

-8.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

9.32

Current EV/EBITDA

11.70

Overvalued EV/EBITDA

12.23

Undervalued EV/EBITDA

6.40

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued

5Y Average PS

0.71

Current PS

0.28

Overvalued PS

0.86

Undervalued PS

0.56